These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 13735870)

  • 21. [Microcrystalloscopic and chemical identification of a pyrimido-pyrimidine derivative (persantin)].
    Yalçindağ ON; Onur E
    Turk Hij Tecr Biyol Derg (1961); 1966; 26(2):163-9. PubMed ID: 5963393
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical evaluation of 4-propylamino-1H-pyrazolo [3,4-d]pyrimidine (NSC-4928).
    SCOTT JL; FOYE LV
    Cancer Chemother Rep; 1962 Jul; 20():73-80. PubMed ID: 14039100
    [No Abstract]   [Full Text] [Related]  

  • 23. [The distribution of 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)pyrimidine in organs and in the myocardial cells of rats and mice].
    KUNZ W; MUELLER E; SIESS M
    Arzneimittelforschung; 1963 Mar; 13():179-85. PubMed ID: 13927400
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of the coronary patient with a pyrimido-pyrimidine derivative].
    VUYLSTEEK K; COLLE R; LAURIJSSENS M; VAN DER STRAETEN M
    Belg Tijdschr Geneesk; 1962 Sep; 18():884-99. PubMed ID: 13998071
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects on the normal and pathological cerebral electrical activity of a pyrimido-pyrimidine derivative].
    SERRA C; MUNICCHI L; ROTONDI SERRA F
    Riv Neurol; 1962; 32():536-73. PubMed ID: 13988103
    [No Abstract]   [Full Text] [Related]  

  • 26. [Persantin, a new substance for therapy of coronary insufficiency].
    JUNEMANN P
    Munch Med Wochenschr; 1959 Feb; 101(8):340-1. PubMed ID: 13644100
    [No Abstract]   [Full Text] [Related]  

  • 27. [Coronary dilator action of 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)pyrimidine: experimental coronary radiographic findings].
    ROVELLI F; BARBACCIA F; DISTANTE S; DONATELLI R
    Atti Soc Ital Cardiol; 1962; 22(2)():Comunicazioni 72-4. PubMed ID: 13982780
    [No Abstract]   [Full Text] [Related]  

  • 28. Antineoplastic effect of the pyrimido-pyrimidine derivative: RA 233.
    Biddle W; Montagna RA; Leong SS; Horoszewicz J; Gastpar H; Ambrus JL
    Pathol Biol (Paris); 1984 Jan; 32(1):9-13. PubMed ID: 6701010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on platelet aggregation in vivo. VI. Effect of a pyrimido-pyrimidine derivative [RA233] on tumor cell metastasis.
    Ambrus JL; Ambrus CM; Gastpar H
    J Med; 1978; 9(2):183-6. PubMed ID: 276567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical studies on the effect of persantin (2, 6-bis (diethanolamino)-4 8-dipiperidino-pyrimido (5, 4-d) pyrimidine in angina pectoris].
    HAMM J; RENSCHLER HE; ZACK WJ
    Medizinische; 1959 Jan; 4(3):120-3. PubMed ID: 13643401
    [No Abstract]   [Full Text] [Related]  

  • 31. Tyrosine kinase inhibitors. 12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor.
    Rewcastle GW; Bridges AJ; Fry DW; Rubin JR; Denny WA
    J Med Chem; 1997 Jun; 40(12):1820-6. PubMed ID: 9191958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of some pyrimidine, pyrimido[2,1-b][1,3]thiazine and thiazolo[3,2-a]pyrimidine derivatives.
    Sayed HH; Shamroukh AH; Rashad AE
    Acta Pharm; 2006 Jun; 56(2):231-44. PubMed ID: 16613728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of coronary insufficiency with persantin].
    TETZLAFF H; TETZLAFF D
    Med Monatsschr; 1959 Apr; 13(4):229-31. PubMed ID: 13656374
    [No Abstract]   [Full Text] [Related]  

  • 34. [Observations on the treatment of myocardial infarct with 2-6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-5,4-d)-pyrimidine (Persantin) in slow venous perfusion].
    Marangoni R; Brera V; Ferrari A
    Minerva Cardioangiol; 1966 Jun; 14(6):373-9. PubMed ID: 5917541
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical experiences and experimental studies on a new pyrimido-pyrimidine derivative].
    KNIPPING HW; BOLT W; MIKULICZ K
    Arzneimittelforschung; 1960 May; 10():364-9. PubMed ID: 14410137
    [No Abstract]   [Full Text] [Related]  

  • 36. [Persantin in cardiology].
    GARAY LILLO J
    Med Esp; 1960 Oct; 44():331-7. PubMed ID: 13703440
    [No Abstract]   [Full Text] [Related]  

  • 37. [Our experience with persantin].
    FERRARO A
    Rass Int Clin Ter; 1961 Jul; 41():654-6. PubMed ID: 13699072
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of coronary insufficiency with high doses of pyrimido-pyrimidine].
    D'Anelli A
    Minerva Cardioangiol; 1970 Feb; 18(2):141-6. PubMed ID: 5446673
    [No Abstract]   [Full Text] [Related]  

  • 39. The synthesis and antibacterial activity of 3-alkyl derivatives of some pyrimido[4,5-d] pyrimidine.
    Cieplik J; Pluta J; Gubrynowicz O
    Acta Pol Pharm; 2003; 60(6):487-92. PubMed ID: 15080598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regiospecific one-pot synthesis of pyrimido[4,5-d]pyrimidine derivatives in the solid state under microwave irradiations.
    Prajapati D; Gohain M; Thakur AJ
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3537-40. PubMed ID: 16650990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.